Aripiprazole in Patients With Acute Mania

Otsuka

Status and phase: Completed; Phase 3

Conditions: Bipolar Disorder

Treatments: Drug: aripiprazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00095511

CN138-135

Details and patient eligibility

About

The purpose of this trial is to test the safety & efficacy of aripiprazole in patients with Bipolar Mania for a period of at least 12 weeks.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Primary diagnosis of Acute Bipolar I Mania

Exclusion criteria

• Patients with a DSM-IV diagnosis other than Bipolar I Mania

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind